ESR2 and cancer: The biphasic activity of phytoestrogen has been underlined during cancer development in estrogen-sensitive tissues: at the earlier stages, phytoestrogen is able to downregulate cell growth by activating ER-β, and in later stages, it can promote proliferation of cells that exhibit a high amount of ER-α but little ER-β.